Rocky Mountain Laboratories, LLC v. Prime Labs, LLC and Mako Medical Laboratories, LLC

District Court, D. Utah·Decided July 27, 2026·No. 2:26-cv-00241·Unknown

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF UTAH

ROCKY MOUNTAIN LABORATORIES, MEMORANDUM DECISION AND LLC, a Utah foreign limited liability ORDER GRANTING [12] company, DEFENDANT’S MOTION TO DISMISS

Plaintiff, Case No. 2:26-cv-00241-DBB-DBP

v. District Judge David Barlow

PRIME LABS, LLC, a Utah domestic limited liability company, and MAKO MEDICAL LABORATORIES, LLC, a Utah foreign limited liability company,

Defendants.

Before the court is Mako Medical Laboratories, LLC’s (“Mako”) Motion to Dismiss Plaintiff Rocky Mountain Laboratories, LLC’s (“RML”) Complaint.1 BACKGROUND This case involves allegations that Defendants used deceptive trade practices and defamatory communications to undermine Plaintiff’s reputation and business opportunities. Plaintiff alleges the following: Plaintiff is a laboratory that provides specialized testing services to healthcare providers in Utah and Idaho.2 Defendants Prime Labs, LLC (“Prime Labs”) and Mako are Plaintiff’s competitors in the clinical laboratory market.3 Prime Labs operates in Utah and competes

1 Motion to Dismiss (“MTD”), ECF No. 12, filed May 5, 2026. 2 Compl. ¶ 1, ECF No. 1, filed Mar. 23, 2026. 3 Id. ¶ 2. directly with RML for laboratory testing business in Utah.4 Mako,5 which is a citizen of North

Carolina for jurisdictional purposes, owns Prime Labs.6 In mid-2025, Prime Labs was experiencing significant financial distress.7 Internal communications between Prime Labs employees show concern that Mako would not continue to fund Prime Labs’ losses.8 Prime Labs’ leadership developed a strategy to “dethrone RML and take over the [laboratory testing] market” in Utah by undermining RML’s reputation with healthcare providers and facilities.9 In late 2025, Defendants began distributing letters to assisted living facilities and healthcare providers claiming that RML was engaged in false billing practices.10 The letters were designed to give the appearance that they originated from a government organization, and they included the name and title of a special agent that had previously interacted with Prime Labs, though the phone number listed did not belong to the agent.11 Prior to the letters being mailed,

Prime Labs employees contacted the healthcare facilities and notified them that they would soon receive letters warning of RML’s alleged fraud.12 After the letters were discovered, the Utah Attorney General’s Office began to investigate the matter.13 As part of the investigation, law enforcement seized the cell phone of a Prime Labs employee.14 It contained communications showing that Prime Labs personnel discussed the

4 Id. ¶ 21. 5 Id. ¶ 42. 6 Id. ¶ 9. 7 Id. ¶ 22. 8 Id. ¶ 23. 9 Id. ¶¶ 25–27. 10 Id. ¶ 28. 11 Id. ¶¶ 28–37. 12 Id. ¶¶ 38–39. 13 Id. ¶ 44. 14 Id. ¶¶ 45. creation and distribution of the letters months before they were mailed.15 Specifically, Prime

Labs employees discussed how to make the letters appear more official and how to increase revenue following the letter campaign.16 Plaintiff also alleges on information and belief that Mako conspired with Prime Labs and participated in distributing the letters.17 STANDARD “Dismissal under Rule 12(b)(6) is appropriate only if the complaint, viewed in the light most favorable to plaintiff, lacks enough facts to state a claim to relief that is plausible on its face.”18 “A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.”19 “In evaluating a motion to dismiss, the court must take as true all well-pleaded facts, as

distinguished from conclusory allegations, view all reasonable inferences in favor of the nonmoving party, and liberally construe the pleadings.”20 Conclusory statements and legal conclusions are “not entitled to the assumption of truth.”21 Generally, “a motion to dismiss should be converted to a summary judgment motion if a party submits, and the district court considers, materials outside the pleadings.”22 “However, notwithstanding the usual rule that a court should consider no evidence beyond the pleadings on

15 Id. ¶ 48. 16 Id. ¶¶ 45–53. 17 Id. ¶ 43. 18 Abdi v. Wray, 942 F.3d 1019, 1025 (10th Cir. 2019) (citing United States ex rel. Reed v. KeyPoint Gov’t Sols., 923 F.3d 729, 764 (10th Cir. 2019)). 19 Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citation omitted). 20 McNellis v. Douglas Cnty. Sch. Dist., 116 F.4th 1122, 1130–31 (10th Cir. 2024) (quoting Reznik v. inContact, Inc., 18 F.4th 1257, 1260 (10th Cir. 2021)) (also quoting Ruiz v. McDonnell, 299 F.3d 1173, 1181 (10th Cir. 2002)) (cleaned up). 21 Iqbal, 556 U.S. at 1951 (emphasis omitted). 22 Alvarado v. KOB-TV, L.L.C., 493 F.3d 1210, 1215 (10th Cir. 2007) (quoting Prager v. LaFaver, 180 F.3d 1185, 1188 (10th Cir. 1999)). a Rule 12(b)(6) motion to dismiss, ‘the district court may consider documents referred to in the complaint if the documents are central to the plaintiff's claim and the parties do not dispute the documents’ authenticity.’”23 Courts may also consider “documents that the complaint incorporates by reference,”24 “documents attached as exhibits to the complaint,”25 and “matters of which a court may take judicial notice,”26 including “facts which are a matter of public record.”27 DISCUSSION Mako moves to dismiss all claims against it because (1) the Complaint does not state a claim against Mako and (2) the court lacks personal jurisdiction over Mako.28 I. Failure to State a Claim

Mako first contends that dismissal is proper under Rule 12(b)(6) of the Federal Rules of Civil Procedure because the Complaint only includes facts showing Prime Labs’ alleged misconduct.29 Mako argues that Plaintiff improperly groups it with Prime Labs as “Defendants” throughout most of the Complaint and that the only allegations relating specifically to Mako are conclusory.30 RML responds that the court must consider the Complaint’s allegations as a whole.31 Plaintiff argues that the Complaint includes numerous facts that implicate Mako,

Free access — add to your briefcase to read the full text and ask questions with AI

Rocky Mountain Laboratories, LLC v. Prime Labs, LLC and Mako Medical Laboratories, LLC, (D. Utah 2026).

Rocky Mountain Laboratories, LLC v. Prime Labs, LLC and Mako Medical Laboratories, LLC (Rocky Mountain Laboratories, LLC v. Prime Labs, LLC and Mako Medical Laboratories, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Prager v. LaFaver
180 F.3d 1185 (Tenth Circuit, 1999)
Oxendine v. Kaplan
241 F.3d 1272 (Tenth Circuit, 2001)
Pro Axess, Inc. v. Orlux Distribution, Inc.
428 F.3d 1270 (Tenth Circuit, 2005)
Tal v. Hogan
453 F.3d 1244 (Tenth Circuit, 2006)
Nasious v. Two Unknown B.I.C.E. Agents
492 F.3d 1158 (Tenth Circuit, 2007)
Alvarado v. KOB-TV, L.L.C.
493 F.3d 1210 (Tenth Circuit, 2007)
Dudnikov v. Chalk & Vermilion Fine Arts, Inc.
514 F.3d 1063 (Tenth Circuit, 2008)
Gee v. Pacheco
627 F.3d 1178 (Tenth Circuit, 2010)
RUIZ v. McDONNELL
299 F.3d 1173 (Tenth Circuit, 2002)
Dutcher v. Matheson
840 F.3d 1183 (Tenth Circuit, 2016)
Moya v. Garcia
895 F.3d 1229 (Tenth Circuit, 2018)